learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
Search
for
Did you mean Osteopontin?
Learn
1 / 1 resultsResearch
5 / 188 resultsresearch Basal Cell Carcinoma With Matrical Differentiation: Expression of Beta-Catenin and Osteopontin
Basal cell carcinoma with matrical differentiation is a rare type linked to hair follicles, with .-catenin important for its development.
research An Osteopontin-Derived Peptide Inhibits Human Hair Growth by Decreasing Fibroblast Growth Factor-7 Production in Outer Root Sheath Keratinocytes
FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.
research Osteopontin Gene Is Expressed in the Dermal Papilla of Pelage Follicles in a Hair-Cycle-Dependent Manner
The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.
research Osteopontin: A New Facilitating Factor in Alopecia Areata Pathogenesis?
Osteopontin may play a role in alopecia areata, but its levels don't predict treatment success.
research Identification of an Osteopontin-Derived Peptide That Binds Neuropilin-1 and Activates Vascular Repair Responses and Angiogenesis
FOL-026 peptide may help hair growth and cardiovascular health by improving blood flow and cell functions.
Community Join
5 / 20 resultscommunity SCUBE3 IS A GO! Clinical trials planned for later this year
SCUBE3 clinical trials for hair loss treatment to start this year. Treatment may involve regular, painless scalp injections to maintain hair growth.
community Amplifica and AMP-303 clinical phase 1
Amplifica is testing a compound called AMP-303 for hair loss, but it's not Scube3 or osteopontin. The timing for the results from the clinical trial is unknown.
community Amplifica Sees Positive Results for Hair Loss Treatment - Results Show 15% increase in 60 days!
Amplifica's new injectable treatment for androgenetic alopecia shows a 15% increase in hair thickness and coarseness in 60 days. The treatment is in early human trials and offers a promising alternative to hormone-related hair loss treatments.
community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025
Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.
community Found an interesting little article
A new painless microneedle patch shows promise in reversing hair loss. The discussion focuses on potential new treatments beyond common options like Minoxidil, finasteride, and RU58841.